Stock NUWE NUWELLIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Nuwellis, Inc.

Equities

NUWE

US67113Y4052

Market Closed - Nasdaq
Other stock markets
 21:00:00 08/05/2024 BST 		5-day change 1st Jan Change
0.26 USD -1.29% Intraday chart for Nuwellis, Inc. +95.49% -55.24%
05-07 Top Midday Gainers MT
05-07 Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Top Midday Gainers
MT
Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Earnings Flash (NUWE) NUWELLIS Reports Q1 Revenue $1.9M, vs. Street Est of $2M
MT
Nuwellis, Inc. Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology
CI
Nuwellis, Inc. Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health
CI
Nuwellis, Inc. Announces Results from Two New Clinical Data Analyses from the AVOID-HF Trial, Which Demonstrate the Benefits of its Aquadex System in Reducing Heart Failure Readmissions at 30 Days
CI
Nuwellis, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Earnings Flash (NUWE) NUWELLIS Reports Q4 Revenue $2.6M
MT
Nuwellis, Inc. Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter
CI
Nuwellis, Inc. Announces New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring Foriatric Patients
CI
Nuwellis, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Earnings Flash (NUWE) NUWELLIS Reports Q3 Revenue $2.4M
MT
Nuwellis Provides Regulatory Update on Seastar Medical's Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under A Humanitarian Device Exemption
CI
Earnings Flash (NUWE) NUWELLIS Reports Q2 Revenue $2.1M, vs. Street Est of $2.19M
MT
Nuwellis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Nuwellis Signs Supply, Collaboration Agreement With DaVita for Aquadex Ultrafiltration Therapy Pilot Program
MT
Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Earnings Flash (NUWE) NUWELLIS Reports Q1 Revenue $1.8M, vs. Street Est of $2.3M
MT
Nuwellis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Nuwellis, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NUWE Stock
  4. News Nuwellis, Inc.
  5. Highlights